Literature DB >> 8736740

Alginate polycation microcapsules. I. Interaction between alginate and polycation.

B Thu1, P Bruheim, T Espevik, O Smidsrød, P Soon-Shiong, G Skjåk-Braek.   

Abstract

The interactions between alginate and polycations have been studied by using different labelling techniques. Binding of poly-L-lysine (PLL) to alginate in the gel state is mainly governed by the amount of dissociable negative charges on the bead surface. PLL was found to bind more rapidly to gel beads made from alginate with a high content of mannuronic acid. The binding was enhanced by increasing the alginate concentration on the surface by making inhomogeneous beads. When the capsules were stored in the presence of cations with high affinity for alginate (Ca2+, Sr2+), PLL was washed off. Less PLL is bound to strontium alginate than to calcium alginate beads. Two mechanisms appear to be responsible for the binding of sodium alginate to alginate PLL capsules (coating): (i) an electrostatic interaction between the soluble coating material and excess positive charges on PLL on the surface; (ii) the formation of a calcium alginate gel on the surface owing to leaching of calcium ions from the core. The stability and efficiency of the coating as a function of molecular size and sequential structure of the coating polymer have also been investigated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8736740     DOI: 10.1016/0142-9612(96)84680-1

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  40 in total

1.  In vitro platform establishes antigen-specific CD8+ T cell cytotoxicity to encapsulated cells via indirect antigen recognition.

Authors:  Ying Li; Anthony W Frei; Ethan Y Yang; Irayme Labrada-Miravet; Chuqiao Sun; Yanan Rong; Magdalena M Samojlik; Allison L Bayer; Cherie L Stabler
Journal:  Biomaterials       Date:  2020-06-15       Impact factor: 12.479

2.  A hydrophobically-modified alginate gel system: utility in the repair of articular cartilage defects.

Authors:  Mohammad Kazem Ghahramanpoor; Sayed Alireza Hassani Najafabadi; Majid Abdouss; Fatemeh Bagheri; Mohamadreza Baghaban Eslaminejad
Journal:  J Mater Sci Mater Med       Date:  2011-07-21       Impact factor: 3.896

3.  Protective antibody response following oral vaccination with microencapsulated Bacillus Anthracis Sterne strain 34F2 spores.

Authors:  Jamie Benn Felix; Sankar P Chaki; Yi Xu; Thomas A Ficht; Allison C Rice-Ficht; Walter E Cook
Journal:  NPJ Vaccines       Date:  2020-07-10       Impact factor: 7.344

Review 4.  Encapsulated Islet Transplantation: Where Do We Stand?

Authors:  Vijayaganapathy Vaithilingam; Sumeet Bal; Bernard E Tuch
Journal:  Rev Diabet Stud       Date:  2017-06-12

Review 5.  Stem cell microencapsulation for phenotypic control, bioprocessing, and transplantation.

Authors:  Jenna L Wilson; Todd C McDevitt
Journal:  Biotechnol Bioeng       Date:  2013-01-17       Impact factor: 4.530

Review 6.  Polymeric materials for embolic and chemoembolic applications.

Authors:  Azadeh Poursaid; Mark Martin Jensen; Eugene Huo; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2016-02-26       Impact factor: 9.776

Review 7.  Bulk and nanoscale polypeptide based polyelectrolyte complexes.

Authors:  Amanda B Marciel; Eun Ji Chung; Blair K Brettmann; Lorraine Leon
Journal:  Adv Colloid Interface Sci       Date:  2016-07-02       Impact factor: 12.984

Review 8.  Immunoisolation to prevent tissue graft rejection: Current knowledge and future use.

Authors:  Anu David; James Day; Ariella Shikanov
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-02

Review 9.  Immunoisolation: where regenerative medicine meets solid organ transplantation.

Authors:  Rajesh Pareta; Brian Sanders; Paurush Babbar; Tom Soker; Christopher Booth; John McQuilling; Sittadjody Sivanandane; Robert J Stratta; Giuseppe Orlando; Emmanuel C Opara
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

10.  Alginate/poly-L-lysine microparticles for the intestinal delivery of antisense oligonucleotides.

Authors:  María González Ferreiro; Lloyd G Tillman; Gregory Hardee; Roland Bodmeier
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.